Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
9.29
-0.22 (-2.31%)
May 13, 2025, 4:00 PM - Market closed

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-141.84-159.49-225.25-200.19-207.28-146.23
Upgrade
Depreciation & Amortization
18.7719.2622.2320.9213.958.47
Upgrade
Asset Writedown & Restructuring Costs
7.217.2125.43---
Upgrade
Loss (Gain) From Sale of Investments
-6.52-8.21-9.180.747.230.77
Upgrade
Stock-Based Compensation
51.4653.6162.9155.4843.2524.76
Upgrade
Other Operating Activities
8.879.8713.7310.656.933.34
Upgrade
Change in Accounts Receivable
-1.56-3.742.03-22.65-7.362.61
Upgrade
Change in Inventory
4.535.37-2.840.82-5.2-4.99
Upgrade
Change in Accounts Payable
-5.050.67-5.417.113.947.5
Upgrade
Change in Unearned Revenue
-11.41-10.48-29.29-56.5-57.73-43.39
Upgrade
Change in Other Net Operating Assets
-9.8-9.28-10.68-0.339.53-2.52
Upgrade
Operating Cash Flow
-85.34-95.21-156.32-183.95-192.73-149.68
Upgrade
Capital Expenditures
-3.41-3.66-10.7-16.35-61.75-18.8
Upgrade
Investment in Securities
62.2781.46140.3419.25242.96-98.24
Upgrade
Investing Cash Flow
58.8677.79129.652.91181.21-117.04
Upgrade
Issuance of Common Stock
5.650.242.257.8926.72293.91
Upgrade
Other Financing Activities
---124.380.43-0.32
Upgrade
Financing Cash Flow
5.650.242.25132.2727.15293.59
Upgrade
Net Cash Flow
-20.84-17.18-24.43-48.7815.6326.86
Upgrade
Free Cash Flow
-88.76-98.88-167.02-200.29-254.47-168.49
Upgrade
Free Cash Flow Margin
-46.83%-55.25%-98.09%-108.09%-164.87%-171.26%
Upgrade
Free Cash Flow Per Share
-0.60-0.67-1.16-1.41-1.81-1.28
Upgrade
Cash Interest Paid
8.958.868.990.49--
Upgrade
Levered Free Cash Flow
-21.4-24.48-81.95-90.17-139.1-60.55
Upgrade
Unlevered Free Cash Flow
-14.22-17.24-73.33-87.53-139.1-60.55
Upgrade
Change in Net Working Capital
-4.08-10.6521.7622.463.96-20.53
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q